Another prime example of the utilization of BChE in alimentary tract carcinomas comes from the study of Gensthaler et al. (47), looking at baseline BChE levels in patients with resectable adenocarcinoma of the gastroesophageal junction. This evidence concerns the gene BCHE and adenocarcinoma.